Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rodrigo Dolphini Velasques"'
Autor:
Marcelo Bellesso, Rodrigo Dolphini Velasques, Luis Fernando Pracchia, Beatriz Beitler, Vera Lúcia Aldred, Dalton Alencar Fisher Chamone, Juliana Pereira
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 45, Iss 2, Pp 111-113 (2009)
Estudo retrospectivo que visa analisar a utilidade da biópsia de medula óssea (BMO) bilateral na infiltração de medula óssea (MO) por linfoma difuso de grandes células B (LDGCB). Nossos objetivos foram avaliar a incidência de infiltração uni
Externí odkaz:
https://doaj.org/article/bab750388eda4c9dbf2cee9f1b427cb3
Autor:
Rodrigo Dolphini Velasques, Wellington F da Silva, Marcelo Bellesso, Vanderson Rocha, Juliana Pereira
Publikováno v:
Journal of Oncology. 2022:1-9
Primary mediastinal B-cell lymphoma (PMBCL) is an uncommon disease, consisting of 2–4% of non-Hodgkin lymphomas. Radiotherapy-free DA-EPOCH-R and R-CHOP plus radiotherapy (RT) have been the upfront standard regimens worldwide. However, performing D
Autor:
Marcelo Bellesso, Rodrigo Dolphini Velasques, Vanderson Rocha, Juliana Pereira, WF Silva-Júnior
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S98-S99 (2021)
Introduction Primary Mediastinal B-cell Lymphoma (PMBCL) is an uncommon entity, comprising less than 4% of non-Hodgkin lymphomas. R-CHOP plus radiotherapy (RT) has been the standard upfront regimen but DA-EPOCH-R has enabled better results with the p
Autor:
Marcelo Junqueira Atanazio, Vanderson Rocha, Giancarlo Fatobene, Valeria Buccheri, Fernanda Maria Santos, Marcelo Bellesso, Rodrigo Dolphini Velasques
Publikováno v:
Hematological Oncology. 39:134-136
Autor:
Marcelo Junqueira, Atanazio, Fernanda Maria, Santos, Amanda, Duran, Ana Carolina Arrais, Maia, Lucas Bassolli, Alves, Rodrigo Dolphini, Velasques, Vanderson, Rocha, Valeria, Buccheri
Publikováno v:
Reports of Practical Oncology and Radiotherapy. 27:865-862
The role of consolidation mediastinal radiotherapy (RT) for mediastinal bulky disease in advanced-stage classical Hodgkin lymphoma (cHL) is controversial in the positron emission tomography/computed tomography (PET-CT) era.We reviewed the medical cha
Autor:
Vanderson Rocha, A. A. G. S. Brandao, L Bassolli, W. F. S Junior, Luis Alberto de Padua Covas Lage, Rodrigo Dolphini Velasques, H. Visnadi, Felipe Vieira Rodrigues Maciel, Sheila Aparecida Coelho Siqueira, Juliana Pereira, R Shcolnik, A. N. R Abdo, G. Duffles, J. I Beraldo, A Duran, I. C Soares, Marcelo Bellesso, R. B Melo
Publikováno v:
Hematological Oncology. 39
Autor:
Rodrigo Dolphini Velasques, Juliana Pereira, Vanderson Rocha, Wellington F Silva, Marcelo Bellesso
Publikováno v:
Hematological Oncology. 39
Autor:
Gabriela Matos Falcão Targueta, Giancarlo Fatobene, Vanderson Rocha, Frederico Rafael Moreira, Fernanda Maria Santos, Valeria Buccheri, Rodrigo Dolphini Velasques, Camila da Cruz Gouveia Linardi
Publikováno v:
Hematological oncologyREFERENCES. 37(3)
Autor:
Dalton Alencar Fisher Chamone, Luis Fernando Pracchia, Juliana Pereira, Vera Lucia Aldred, Rodrigo Dolphini Velasques, Marcelo Bellesso, Beatriz Beitler
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Volume: 45, Issue: 2, Pages: 111-113, Published: APR 2009
Jornal Brasileiro de Patologia e Medicina Laboratorial v.45 n.2 2009
Jornal Brasileiro de Patologia e Medicina Laboratorial
Sociedade Brasileira de Patologia (SBP)
instacron:SBP
Jornal Brasileiro de Patologia e Medicina Laboratorial v.45 n.2 2009
Jornal Brasileiro de Patologia e Medicina Laboratorial
Sociedade Brasileira de Patologia (SBP)
instacron:SBP
Estudo retrospectivo que visa analisar a utilidade da biópsia de medula óssea (BMO) bilateral na infiltração de medula óssea (MO) por linfoma difuso de grandes células B (LDGCB). Nossos objetivos foram avaliar a incidência de infiltração uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e016e0bf6565c6e519bb4944c302f4
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442009000200004&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442009000200004&lng=en&tlng=en
Autor:
Marcelo Bellesso, Marcela Cavalcante de Andrade Silva, Rodrigo Dolphini Velasques, Helena Visnadi, Roberta Shcolnik, Fernanda Salles Seguro, Debora Levy, Andre Neder Ramires Abdo, Rodrigo Santucci, Juliana Pereira, Gracia Aparecida Martinez
Publikováno v:
Blood. 122:5385-5385
Background Nowadays, the best evidence for symptomatic patients with Multiple Myeloma (MM) is initial induction therapy with more than two drugs that contains bortezomib. If patients are eligible it is established the use of high dose chemotherapy an